Status:
COMPLETED
DD T2 Daily Disposable Registration Trial
Lead Sponsor:
Alcon Research
Conditions:
Myopia
Refractive Errors
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The purpose of this study is to evaluate the performance of the investigational verofilcon A contact lens compared to the commercially available delefilcon A contact lens, by assessing visual acuity a...
Detailed Description
Enrolled participants will be randomized (2:1) to receive either verofilcon A (test) contact lenses or delefilcon A (control) contact lenses for wear in both eyes and attend 7 office visits: Baseline,...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Successful wear of spherical soft contact lenses for distance correction in both eyes during the past 3 months for a minimum of 5 days per week and 8 hours per day.
- Best corrected VA 20/25 or better in each eye.
- Other protocol-specified inclusion criteria may apply.
- Exclusion Criteria
- Any current or prior wear experience with DT1 lenses.
- Wearing habitual contact lenses in an extended wear modality (routinely sleeping in lenses for at least 1 night per week) over the last 3 months prior to enrollment.
- Other protocol-specified exclusion criteria may apply.
Exclusion
Key Trial Info
Start Date :
October 12 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 21 2018
Estimated Enrollment :
107 Patients enrolled
Trial Details
Trial ID
NCT03305770
Start Date
October 12 2017
End Date
February 21 2018
Last Update
February 22 2019
Active Locations (6)
Enter a location and click search to find clinical trials sorted by distance.
1
Alcon Investigative Site
San Diego, California, United States, 92123
2
Alcon Investigative Site
Longwood, Florida, United States, 32779
3
Alcon Investigative Site
Maitland, Florida, United States, 32751
4
Alcon Investigative Site
Bloomington, Illinois, United States, 61701